BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.195
0.00 (0.00%)
Aug 17, 2026, 4:59 PM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 591.66 million as of August 17, 2026. Its market cap has decreased by -0.05% in one year.
Market Cap
591.66M
Enterprise Value
544.28M
Revenue
40.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.20
ChartMarket Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 591.66M, an increase of 685.95%. That is a compound annual growth rate of 10.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 591.66M | 17.16% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.30T |
| Genmab | 121.01B |
| Coloplast | 96.44B |
| Demant | 62.72B |
| ChemoMetec | 8.06B |
| Gubra | 6.07B |
| ViroGates | 101.17M |
| Pharma Equity Group | 100.17M |